Literature DB >> 9333154

T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen.

A J Quayle1, C Xu, K H Mayer, D J Anderson.   

Abstract

The cellular fraction of semen contains spermatozoa, immature germ cells, leukocytes, and epithelial cells. Recent evidence implicates seminal cells as a major source of sexually transmitted human immunodeficiency virus (HIV) in semen, but the identity and infectious potential of infected cells remains poorly understood. HIV provirus was found in 75% of viable semen cell samples by polymerase chain reaction and in 88% of paired blood cell samples from HIV-seropositive men. When semen cell subpopulations were isolated by an immunomagnetic bead technique, T cells were found to be most commonly HIV-infected (75% of samples), followed by macrophages (38% of samples). Viral DNA was never detected in motile spermatozoa or immature germ cell populations. Semen leukocytes proliferated in response to mitogenic and antigenic challenge and produced p24 following stimulation with irradiated allogeneic cells. These data provide evidence that both T cells and macrophages, but not germ cells, are cellular vectors of HIV transmission in semen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333154     DOI: 10.1086/516541

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  58 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 2.  Use of assisted reproductive technology to reduce the risk of transmission of HIV in discordant couples wishing to have their own children where the male partner is seropositive with an undetectable viral load.

Authors:  H W G Baker; A Mijch; S Garland; S Crowe; M Dunne; D Edgar; G Clarke; P Foster; J Blood
Journal:  J Med Ethics       Date:  2003-12       Impact factor: 2.903

3.  Antiretroviral therapy as HIV prevention: status and prospects.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

Review 4.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

5.  HIV latency: present knowledge, future directions.

Authors:  Xavier Contreras; Tina Lenasi; B Matija Peterlin
Journal:  Future Virol       Date:  2006       Impact factor: 1.831

6.  HIV binding, penetration, and primary infection in human cervicovaginal tissue.

Authors:  Diane Maher; Xiaoyun Wu; Timothy Schacker; Julie Horbul; Peter Southern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

Review 7.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

Review 8.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

9.  Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance.

Authors:  Cherry Kingsley; Barry Peters; Kaboutar Babaahmady; Laura Pomeroy; Durdana Rahman; Robert Vaughan; Thomas Lehner
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

10.  Leukocytospermia and sperm preparation--a flow cytometric study.

Authors:  Giuseppe Ricci; Sandra Perticarari; Rita Boscolo; Roberto Simeone; Monica Martinelli; Leo Fischer-Tamaro; Secondo Guaschino; Gianni Presani
Journal:  Reprod Biol Endocrinol       Date:  2009-11-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.